Little after 10:00 nice vol stick on VUZI... all technicals look to be pointing UP.
Ideas For Now-
- Thread starter stonedinvestor
- Start date
VAN watch HGEN.
This might be the better $1 move....
It's only one patient so you know this improvement could be attributed to anything...
BUT->
Humanigen Announces COVID-19 Case Report Demonstrating Rapid Resolution and Discharge after Single IND Emergency Use Authorization of Lenzilumab(TM)
ACCESSWIRE•October 2, 2020
The published case describes a 77-year-old Caucasian male patient with a past medical history of type II diabetes, coronary artery disease with coronary artery bypass graft, systolic heart failure, severe chronic obstructive pulmonary disease (COPD) with emphysema and obstructive sleep apnea. The patient tested positive for SARS-CoV-2 and was admitted to the ICU in March 2020 for COVID-19 and put on respiratory isolation. MARCH!!!
The patient was treated with steroids, broad spectrum antibiotics for community acquired pneumonia and bronchodilators for possible COPD exacerbation and hydroxychloroquine with zinc. The patient continued to deteriorate for the next 12 weeks with an increase in oxygen demand from continuous low-flow oxygen to high-flow and eventually intermittent bilevel positive airway pressure (BIPAP) and developed acute respiratory distress syndrome (ARDS) during that time.<-- serious
At week 13 of hospitalization and multiple unsuccessful attempts at oxygen weaning, an emergency single use IND for lenzilumab, Humanigen's Humaneered®anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody drug candidate, was approved by the FDA and administered to the patient. Seven days following the administration of lenzilumab, the patient's oxygen decreased from high-flow to low-flow nasal cannula and the patient was able to walk outside of his hospital room with physical therapy. Sixteen days post-treatment with lenzilumab, the patient was discharged from the hospital on home oxygen.
16 days later he walks out!
Lenzilumab is being evaluated in an ongoing Phase 3 trial....
This might be the better $1 move....
It's only one patient so you know this improvement could be attributed to anything...
BUT->
Humanigen Announces COVID-19 Case Report Demonstrating Rapid Resolution and Discharge after Single IND Emergency Use Authorization of Lenzilumab(TM)
ACCESSWIRE•October 2, 2020
- Case report demonstrated rapid resolution of hypoxemia and mobility and potential benefit of lenzilumab beyond the initial acute hyper-inflammatory window
- After 13 weeks of hospitalization, administration of lenzilumab resulted in rapid improvement in oxygenation and subsequent discharge
The published case describes a 77-year-old Caucasian male patient with a past medical history of type II diabetes, coronary artery disease with coronary artery bypass graft, systolic heart failure, severe chronic obstructive pulmonary disease (COPD) with emphysema and obstructive sleep apnea. The patient tested positive for SARS-CoV-2 and was admitted to the ICU in March 2020 for COVID-19 and put on respiratory isolation. MARCH!!!
The patient was treated with steroids, broad spectrum antibiotics for community acquired pneumonia and bronchodilators for possible COPD exacerbation and hydroxychloroquine with zinc. The patient continued to deteriorate for the next 12 weeks with an increase in oxygen demand from continuous low-flow oxygen to high-flow and eventually intermittent bilevel positive airway pressure (BIPAP) and developed acute respiratory distress syndrome (ARDS) during that time.<-- serious
At week 13 of hospitalization and multiple unsuccessful attempts at oxygen weaning, an emergency single use IND for lenzilumab, Humanigen's Humaneered®anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody drug candidate, was approved by the FDA and administered to the patient. Seven days following the administration of lenzilumab, the patient's oxygen decreased from high-flow to low-flow nasal cannula and the patient was able to walk outside of his hospital room with physical therapy. Sixteen days post-treatment with lenzilumab, the patient was discharged from the hospital on home oxygen.
16 days later he walks out!
Lenzilumab is being evaluated in an ongoing Phase 3 trial....
Van on 9/18 did almost 2 mil vol.... they are calling it an IPO? But it charts back further any help here<<<
Humanigen prices 8M-share IPO at $8.50
Sep. 18, 2020 3:41 AM ET|About:Humanigen, Inc. (HGEN)|
Humanigen (OTCQB:HGEN)haspricedits public offering of 8M common shares at $8.50/share, resulting in gross proceeds of ~$68M.
Nasdaq trading commences on September 18.
Underwriters' over-allotment is an additional 1.2M shares.
Net proceeds will be used for commercialization of lenzilumab and for general corporate purposes.
Closing date is September 22.
Humanigen prices 8M-share IPO at $8.50
Sep. 18, 2020 3:41 AM ET|About:Humanigen, Inc. (HGEN)|
Humanigen (OTCQB:HGEN)haspricedits public offering of 8M common shares at $8.50/share, resulting in gross proceeds of ~$68M.
Nasdaq trading commences on September 18.
Underwriters' over-allotment is an additional 1.2M shares.
Net proceeds will be used for commercialization of lenzilumab and for general corporate purposes.
Closing date is September 22.
Wait this is that stock that Martin Schinkle or whatever we covered these guys... used to be called something else.
Humanigen to effect 1-for-5 reverse stock split
Sep. 4, 2020 5:08 PM ET|About:Humanigen, Inc. (HGEN)|
To satisfy compliance with Nasdaq's $1 minimum bid <--- Yikes price, Humanigen(OTCQB:HGEN)announces 1-for-5 reverse stock split expected on Sep. 11 AH.
Stock will trade at split-adjusted basis from market open on Sep. 14.<---
Humanigen to effect 1-for-5 reverse stock split
Sep. 4, 2020 5:08 PM ET|About:Humanigen, Inc. (HGEN)|
To satisfy compliance with Nasdaq's $1 minimum bid <--- Yikes price, Humanigen(OTCQB:HGEN)announces 1-for-5 reverse stock split expected on Sep. 11 AH.
Stock will trade at split-adjusted basis from market open on Sep. 14.<---
Kalo Bio... some connection.
I checked our holdings and only two names have large gains--
WIMHY +74%
COOP +30%
I am still betting on a stimulus bill & rally! But will probably sell those two fairly shortly....
I checked our holdings and only two names have large gains--
WIMHY +74%
COOP +30%
I am still betting on a stimulus bill & rally! But will probably sell those two fairly shortly....
BUY BERRY NOW! NAZ DOWN 200 BERY POINTING UP I THINK THIS IS FINALLY THE BREAKOUT>>> ALL MY INDICATORS ARE GREEN INCLUDING MY GUMMY!!!
Berry Global Group, Inc. (BERY)
NYSE - Nasdaq Real Time Price. Currency in USD
$49.83.. <------------ VAN!
+0.49 (+0.99%)
Berry Global Group, Inc. (BERY)
NYSE - Nasdaq Real Time Price. Currency in USD
$49.83.. <------------ VAN!
+0.49 (+0.99%)
DAVID'S TEA IS UP!
DAVIDsTEA Inc. (DTEA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.1950+0.0550 (+4.82%)<-------
As of 11:46AM EDT.
DAVIDsTEA Inc. (DTEA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.1950+0.0550 (+4.82%)<-------
As of 11:46AM EDT.
VMC IS UP!
Vulcan Materials Company (VMC)
NYSE - Nasdaq Real Time Price. Currency in USD
136.98+2.60 (+1.93%)<-----
As of 11:46AM EDT.
Vulcan Materials Company (VMC)
NYSE - Nasdaq Real Time Price. Currency in USD
136.98+2.60 (+1.93%)<-----
As of 11:46AM EDT.
DAL is a nice long daytrade going into the close here at $31.65.
Its gonna squeeze hard as a million retail shorts jumped on that pop earlier.
Just put a stop under it just in case. Like $31.19
EDIT: If you want a nice $100 lottery ticket, buy 20 of today's $32 calls for a nickle right now.
Its gonna squeeze hard as a million retail shorts jumped on that pop earlier.
Just put a stop under it just in case. Like $31.19
EDIT: If you want a nice $100 lottery ticket, buy 20 of today's $32 calls for a nickle right now.
Last edited:
Oh I thnk DAL going much higher Van i own at $55!!
Looking for a move to mid $40's at least....
Watch>
Stewart Information Services Corporation (STC)
NYSE - Nasdaq Real Time Price. Currency in USD
45.35+0.93 (+2.09%)<-----
As of 1:56PM E
Looking for a move to mid $40's at least....
Watch>
Stewart Information Services Corporation (STC)
NYSE - Nasdaq Real Time Price. Currency in USD
45.35+0.93 (+2.09%)<-----
As of 1:56PM E